Vytrus Biotech SA
BBME:VYT15.00
EUR
+0.70
(+4.90%)
ISIN
ES0105618005
Return %
Stock
S&P 500
1Y
154.24
14.20
3Y
504.84
81.12
5Y
- -
68.34
Capital Structure
EUR
•
in mil. unless spec.Working Capital
EUR
•
in mil. unless spec.Growth Rates
EUR
•
in mil. unless spec.Semi-annual Revenue
EUR
•
in mil. unless spec.Semi-annual Earnings Per Share
EUR
•
in mil. unless spec.Semi-annual Dividends Per Share
EUR
•
in mil. unless spec.Company Description
- Full Time Employees
- 48
- Sector
- Health technology
- Industry
- Biotechnology
- Address
- Barcelona Spain
- IPO Date
- Mar 15, 2022
- Website
- vytrus.com
- Similar Companies
- Business
- Vytrus Biotech, S.A. (BME: VYT) is a Spain-based biotechnology company that researches, develops, produces, and commercializes plant-derived active ingredients and biological raw materials for the cosmetics, dermatology, and personal care industries. Founded in 2009 and headquartered in Terrassa (Barcelona), Spain, the company specializes in plant stem cell culture technology, utilizing proprietary and sustainable in vitro cell cultivation platforms to produce high-value phytocomplexes and bioactive substances without depleting natural resources or employing genetic modification. The company operates primarily within the specialty cosmetic ingredients sector, serving industrial cosmetics manufacturers, dermopharmaceutical laboratories, and personal care brand owners worldwide. Vytrus Biotech's commercial product portfolio consists of proprietary active ingredients organized by biological functionality and cosmetic application, including Capilia Longa, a hair growth stimulant and density enhancer derived from Curcuma longa totipotent cells; Centella Reversa, a skin-rejuvenating and tissue-regeneration active derived from Centella asiatica; Quora Noni, a microbiome-balancing and anti-acne active derived from Morinda citrifolia; Olea Vitae, a cellular energy activator and anti-wrinkle active derived from wild olive tree stem cells; Kannabia Sense, a neurocosmetic prebiotic active derived from Cannabis sativa stem cells designed to stimulate skin oxytocin pathways; Deobiome Noni, an axillary microbiota-modulating biological deodorant active; Nectaria Lithops, a cellular hydration and skin vitamin D booster derived from Lithops pseudotruncatella; Elaya Renova, a hair, scalp, and eyebrow architecture restructuring ingredient; Photobiome, a sun care active engineered to protect and activate skin microbiota against photoaging; and Baolift, a skin-firming and lifting active derived from Adansonia digitata stem cells. In addition to catalog ingredients, the company provides custom contract research and development, proprietary active design, and customized plant cell culture manufacturing services for international cosmetic brand formulation programs. Vytrus Biotech operates internationally across Europe, North America, Latin America, and the Asia-Pacific region through an established network of regional chemical and cosmetic ingredient distributors in more than 30 countries. In recent strategic and operational developments, Vytrus Biotech has expanded its commercial reach and technological infrastructure following its listing on the BME Growth exchange. The company has enhanced its technological platforms through the development of plant exosomes and advanced Phyto-Peptidic Fractions, augmenting its active ingredient pipeline for prestige skin and hair care applications. Vytrus Biotech has launched new commercial actives, including Photobiome, which garnered multiple international industry honors at global cosmetics expositions. To support ongoing volume growth in export markets, the company has scaled its industrial production capacity at its Terrassa biotechnology facility, incorporating advanced bioreactor systems and automated quality control infrastructure. Additionally, Vytrus Biotech has expanded its strategic distribution partnerships across the United States, Latin America, and key Asia-Pacific markets, broadening the integration of its biotechnological active ingredients into international consumer brands.